NCT00745355Active, not recruiting
Quality of Life in Patients With Bladder Cancer
A Prospective Study of Quality of Life in Patients With Bladder Cancer
Source: ClinicalTrials.gov · Last updated 25 Sept 2026
Brief summary (registry, in English)
The purpose of this study is to learn about the quality of life of people living with bladder cancer. We are interested in learning about how the treatments for bladder cancer affect people. We plan to use the findings from this study to help doctors provide better care and information to patients with bladder cancer.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 550 (estimated)
- First submitted
- 22 Aug 2008
- Start date
- 1 Aug 2008
- Primary completion date
- 31 Aug 2027
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Diseases
- Bladder cancer
- NCT number
- NCT00745355
What you commit to
- Study type: Observational
- Planned participants: 550
- From 1 Aug 2008 to the primary completion date, 31 Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Metastatic disease at diagnosis.
Other
- Subjects may be excluded from the study based on the following criteria:
- Follow-up care not obtained at MSKCC.
Who the study is looking for
- All patients (male and female) who are diagnosed with bladder cancer
- Patients must be scheduled for radical cystectomy and urinary diversion are and/or being evaluated for neo-adjuvant chemotherapy prior to a planned cystectomy.
- Participants must be able to speak English.
- Participants must be able to provide informed consent.
- Participants must be 18 years of age or older to enroll.
- Participant may be eligible for and may receive neoadjuvant or adjuvant chemotherapy.
- Participant may have had intravesicle chemotherapy or immunotherapy (BCG, Interferon).
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Memorial Sloan-Kettering Cancer Center Coordinator of this site? Confirm its status | New York | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.